French manufacturer, CarThera, recently announced that the US Food & Drug Administration (FDA) has granted approval to begin a US clinical trial of their SonoCloud-9 ultrasound device in patients with recurrent glioblastoma (GBM).
Foundation Research Assistant, Isabella Small, recently spoke with her grandfather, Albert Small, about why he is excited about focused ultrasound’s impact on medicine.